SavedAdd your journal

Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 8

Evaluation of the relationship between sociodemographiccharacteristics, quality of life, depression, drugcompliance and biochemical parameters in patients withthalassemia major in Isparta

Emine GÜÇHAN ALANOĞLU
Aslıhan BADUR
Demircan ÖZBALCI
Pages
1500–1507
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The general health perception of patients with minimal depression was higher than those with moderate depression and severe depression.Conclusions: Psychosocial support of patients is important and, therapy should be aimed not only to ensure long life without complications but also improve the quality of life of the patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to evaluate the quality of life and depression levels of BTM patients in our unit, to determine the relationship between each parameter and evaluate the demographic characteristics, laboratory data, and treatment compliance.Materials and Methods: Twenty-seven BTM patients aged 18 years and over were included in the study.
📊
Key Findings & Data:The patients were asked to respond to the BDI and SF-36 content in which depression was questioned and quality of life was evaluated respectively.
💡
Conclusion & Impact:The general health perception of patients with minimal depression was higher than those with moderate depression and severe depression.Conclusions: Psychosocial support of patients is important and, therapy should be aimed not only to ensure long life without complications but also improve the quality of life of the patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to evaluate the quality of life and depression levels of BTM patients in our unit, to determine the relationship between each parameter and evaluate the demographic characteristics, laboratory data, and treatment compliance.Materials and Methods: Twenty-seven BTM patients aged 18 years and over were included in the study. Sociodemographic data were collected from the patients with a data form. Laboratory data were obtained from hospital records retrospectively. The patients were asked to respond to the BDI and SF-36 content in which depression was questioned and quality of life was evaluated respectively. The relationship between each parameter was examined.Results: 70,3 % of the patients had minimal-mild and 11,1 % of the patients had severe depression. Depression levels were significantly higher in patients who had a regular job and who had poor compliance to chelation therapy. Physical function and physical role subscales of single patients were significantly higher than married patients. Patients with monthly income had higher quality of life in terms of physical role, mental health, social functioning and pain subscales. The patients without co-morbidity had higher quality of life in terms of physical role, pain and general health subscales. Patients with severe depression had the worst quality of life. The general health perception of patients with minimal depression was higher than those with moderate depression and severe depression.Conclusions: Psychosocial support of patients is important and, therapy should be aimed not only to ensure long life without complications but also improve the quality of life of the patients.

🔖

Cite This Article

ALANOĞLU, E. G., BADUR, A., ÖZBALCI, D. (2022). Evaluation of the relationship between sociodemographiccharacteristics, quality of life, depression, drugcompliance and biochemical parameters in patients withthalassemia major in Isparta. Annals of Medical Research, Cilt: 28 - Sayı: 8, 1500–1507. https://ajindex.com/articles/445953

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am 2013;60:1383-91
  2. Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2012;2 a011692
  3. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86:480-7
  4. Cappellini M-D, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassaemia: Thalassaemia International Federation, Nicosia (CY); 2008
  5. Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev 2012;26:3-6
  6. Kazanci EG, Bektemur G, Bener S, et al. Preimplantation genetic diagnosis in thalassemia and inclusion of the treatment in the scope of reimbursement evaluation. Health Care 2017;4:135
  7. Tunc B, Cetin H, Gumruk F, Istanbullu B, Yavrucuoglu H, et al. The prevalence and molecular basis of betathalassemia in Isparta province and region. Turk J Pediatr 2002;44:18-20
  8. Origa R. β-Thalassemia. Genetics in Medicine. 2017;19:609
  9. Langhi Jr D, Ubiali EMA, Marques Jr JFC, et al. Guidelines on Beta-thalassemia major-regular blood transfusion therapy: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associacao Medica Brasileira-2016. Rev Bras Hematol Hemoter 2016;38:341-5
  10. Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. The Lancet 2018; 391:155-67
  11. Lucarelli G, Isgrò A, Sodani P, et al. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med 2012;2: a011825
  12. Thalassemia gene therapy nears approval. Nat Biotechnol 2019;37:493
  13. Belhoul KM, Bakir ML, Saned M-S, et al. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Ann Hematol 2012;91:1107-14
  14. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis 2010;5:11
  15. Organization WH. Depression and other common mental disorders: global health estimates. World Health Organization; 2017
  16. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984;40:1365-7
  17. Bilge Y, Kulaksizoglu A. A New Scale: Validity and reliability study of the psychological disorders inventory for adolescents. J Int Soc Res 2017;10
  18. Hisli-Sahin N. A study on the validity of the Beck Depression Inventory. Turkish Journal of Psychology 1988;6:118-26